Individual decontamination measures reduce by two the incidence of surgical site infections in spinal surgery.


Journal

Orthopaedics & traumatology, surgery & research : OTSR
ISSN: 1877-0568
Titre abrégé: Orthop Traumatol Surg Res
Pays: France
ID NLM: 101494830

Informations de publication

Date de publication:
Oct 2020
Historique:
received: 09 10 2019
revised: 25 11 2019
accepted: 13 01 2020
pubmed: 7 5 2020
medline: 25 6 2021
entrez: 7 5 2020
Statut: ppublish

Résumé

In spinal surgery, incidence of surgical site infections (SSI) is estimated between 1 and 10%. It results in increased morbidity, mortality and cost of management. Individual Staphylococcus aureus (SA) decolonization has already proved efficiency to prevent those events in various surgical domains. The aim of this study was to evaluate a strategy of prevention of SSI and in particular the decolonization of the nasal carriage of SA by a protocol with Mupirocin application. We conducted a bicentric observational study on 5314 spinal surgery patients over a seven-year period. In both center, we compared periods before and after implementation of two measures: modification of antibioprophylaxis and staphylococcus decolonization. Homogeneity of the different samples of patients was assessed through measure of individual and surgical variables. We measured monthly incidence of SSI and evaluated its evolution in order to assess efficiency of these interventions. The incidence of SSI decreased by half, from 7.3% to 3% at the Beaujon Hospital and from 8.3% to 3.9% at the Georges-Pompidou European Hospital (GPEH). We do not observe any significant decrease of SA rate in these SSI. We believe that Staphylococcus aureus decolonization should be recommended in spinal surgery, and should be combined with an overall improvement of the quality of care.

Sections du résumé

BACKGROUND BACKGROUND
In spinal surgery, incidence of surgical site infections (SSI) is estimated between 1 and 10%. It results in increased morbidity, mortality and cost of management. Individual Staphylococcus aureus (SA) decolonization has already proved efficiency to prevent those events in various surgical domains. The aim of this study was to evaluate a strategy of prevention of SSI and in particular the decolonization of the nasal carriage of SA by a protocol with Mupirocin application.
METHODS METHODS
We conducted a bicentric observational study on 5314 spinal surgery patients over a seven-year period. In both center, we compared periods before and after implementation of two measures: modification of antibioprophylaxis and staphylococcus decolonization. Homogeneity of the different samples of patients was assessed through measure of individual and surgical variables. We measured monthly incidence of SSI and evaluated its evolution in order to assess efficiency of these interventions.
RESULTS RESULTS
The incidence of SSI decreased by half, from 7.3% to 3% at the Beaujon Hospital and from 8.3% to 3.9% at the Georges-Pompidou European Hospital (GPEH). We do not observe any significant decrease of SA rate in these SSI.
CONCLUSION CONCLUSIONS
We believe that Staphylococcus aureus decolonization should be recommended in spinal surgery, and should be combined with an overall improvement of the quality of care.

Identifiants

pubmed: 32371016
pii: S1877-0568(20)30073-6
doi: 10.1016/j.otsr.2020.01.013
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Mupirocin D0GX863OA5

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1175-1181

Informations de copyright

Copyright © 2020 Elsevier Masson SAS. All rights reserved.

Auteurs

Benjamin Bouyer (B)

Service d'orthopédie-traumatologie, hôpital européen Georges-Pompidou, Paris, France; Service d'orthopédie-traumatologie, hôpital européen Georges-Pompidou, université Paris-Descartes, Paris, France. Electronic address: benjamin.bouyer@aphp.fr.

Robin Arvieu (R)

Service d'orthopédie-traumatologie, hôpital européen Georges-Pompidou, Paris, France; Service d'orthopédie-traumatologie, hôpital européen Georges-Pompidou, université Paris-Descartes, Paris, France.

Marie-Paule Gerlinger (MP)

Service d'orthopédie-traumatologie, hôpital européen Georges-Pompidou, université Paris-Descartes, Paris, France; Unité de microbiologie clinique, hôpital européen Georges-Pompidou, université Paris-Descartes, Paris, France.

Laurence Watier (L)

Inserm, UMR 1181 biostatistique, biomathématique, pharmacoépidémiologie et maladies infectieuses (B2PHI), Institut Pasteur, université Versailles Saint-Quentin-en-Yvelines, Saint Quentin en Yvelines, France.

Najiby Kassis (N)

Service d'orthopédie-traumatologie, hôpital européen Georges-Pompidou, université Paris-Descartes, Paris, France; Inserm, UMR 1181 biostatistique, biomathématique, pharmacoépidémiologie et maladies infectieuses (B2PHI), Institut Pasteur, université Versailles Saint-Quentin-en-Yvelines, Saint Quentin en Yvelines, France.

Simone Nerome (S)

Unité d'hygiène et de lutte contre les infections nosocomiales, hôpital Beaujon, Paris, France; Service d'informatique médicale, hôpital Beaujon, université Paris Diderot, Paris, France.

Aziz Diop (A)

Université Paris Diderot, Paris, France; Service d'informatique médicale, hôpital Beaujon, université Paris Diderot, Paris, France.

Jean-Luc Mainardi (JL)

Service d'orthopédie-traumatologie, hôpital européen Georges-Pompidou, université Paris-Descartes, Paris, France; Unité de microbiologie clinique, hôpital européen Georges-Pompidou, université Paris-Descartes, Paris, France.

Pierre Durieux (P)

Service d'informatique médicale, hôpital Beaujon, université Paris Diderot, Paris, France; Service d'informatique médicale, hôpital européen Georges-Pompidou, université Paris-Descartes, Paris, France.

Pierre Guigui (P)

Service d'orthopédie-traumatologie, hôpital européen Georges-Pompidou, Paris, France; Service d'orthopédie-traumatologie, hôpital européen Georges-Pompidou, université Paris-Descartes, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH